RAPT Therapeutics, Inc. Recorded Big Gain
Mon, Dec 23, 2024 at 07:09 PM
RAPT Therapeutics, Inc. (RAPT:NASDAQ) jumped higher at $1.74, a gain of 110.8%. On Mon, Dec 23, 2024, RAPT:NASDAQ touched a New 2-Week High of $1.74. The stock got featured on our News Catalysts scanner on Mon, Dec 23, 2024 at 08:25 AM in the 'PRIVATE PLACEMENT' category. From Mon, Dec 09, 2024, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Dec 23, 2024 at $2.31 with a volume of 140M+.
About RAPT Therapeutics, Inc. (RAPT:NASDAQ)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Top 10 Gainers:
- Direct Digital Holdings Inc. (DRCT:NASDAQ), 900%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 284.62%
- Check-Cap Ltd. (CHEK:NASDAQ), 270.19%
- Traws Pharma Inc. (TRAW:NASDAQ), 150.4%
- Smart for Life Inc. (SMFL:NASDAQ), 118.18%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 110.81%
- Rumble Inc Cl A (RUM:NASDAQ), 81.22%
- SEALSQ Corp. (LAES:NASDAQ), 78.18%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 66.67%
- Fitell Corporation (FTEL:NASDAQ), 65%